Efficacy of Corticosteroids in the Treatment of Community-Acquired Pneumonia Requiring Hospitalization
- First Online:
- 676 Downloads
Recent studies suggested that administration of corticosteroids may improve clinical outcomes in patients with severe pneumonia.
The aim of this study was to assess the effectiveness of corticosteroids as an adjunctive therapy in community-acquired pneumonia (CAP) requiring hospitalization.
Design and Setting
An open label, prospective, randomized control study was conducted from September 2003 to February 2004 in a community general hospital in Japan.
Thirty-one adult CAP patients who required hospitalization were enrolled.
Measurements and Results
Fifteen patients received 40 mg of prednisolone intravenously for 3 days (steroid group). Sixteen patients did not receive prednisolone (control group). Both groups were also evaluated for their adrenal function. The primary endpoint was length of hospital stay. Secondary endpoints were duration of intravenous (IV) antibiotics and time required to stabilize vital signs. Both groups demonstrated similar baseline characteristics and length of hospital stay, and yet a shorter duration of IV antibiotics was observed in the steroid group (p < 0.05). In addition, vital signs were stabilized earlier in the steroid group (p < 0.05). These differences were more prominent in the moderate–severe subgroup but not as significant in the mild–moderate subgroup. The prevalence of relative adrenal insufficiency (RAI) in both groups was high (43%), yet there was no difference in baseline characteristics between patients, with or without RAI. In multiple regression models, RAI seemed to have no influence on clinical courses.
In moderate–severe CAP, administration of corticosteroids promotes resolution of clinical symptoms and reduces the duration of intravenous antibiotic therapy.
KeywordsCommunity-acquired pneumonia Corticosteroids Relative adrenal insufficiency
Relative adrenal insufficiency
Pneumonia severity index
Pneumonia Patient Outcomes Research Team
- 1.Health and Welfare Statistics Association of Japan (2004) Annual Report of National Health and Hygiene in Japan. Kouseinoshihyou 51:382–385 [in Japanese]Google Scholar
- 7.National Institutes of Health / National Heart Lung, Blood Institute (2002) Global Initiative for Asthma. Global strategy for asthma management and prevention. NIH Publ 02–3659Google Scholar
- 9.Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27:723–732PubMedCrossRefGoogle Scholar
- 10.Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871PubMedCrossRefGoogle Scholar
- 15.Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL (2001) American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730–1754PubMedGoogle Scholar
- 19.Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, Anderson P, Morgan NA (1999) Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med 340:1941–1947PubMedCrossRefGoogle Scholar
- 20.Bach PB, Brown C, Gelfand SE, McCrory DC (2001) American College of Physicians–American Society of Internal Medicine; American College of Chest Physicians. Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med 134:600–620PubMedGoogle Scholar